Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCAB-AMI: Zastaprazan vs PPI for GI Protection in AMI Patients on DAPT
NCT07467213Phase 3Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Jun 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zastaprazan in gastrointestinal bleeding, sponsored by Samsung Medical Center. Started Jun 2026; status: recruiting.
02
Drugs
zastaprazan
03
Conditions
gastrointestinal bleeding
Beyond the preview
Go deeper on NCT07467213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07467213.